Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. - sprookjes - yvandenbroek - TriplyDB

Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

http://www.wikidata.org/entity/Q35769113

about

HCV-related nervous system disorders Extrahepatic manifestations of chronic hepatitis C virus infection Molecular and Bioinformatic Evidence of Hepatitis C Virus Evolution in Brain Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy Immune aging, dysmetabolism, and inflammation in neurological diseases.Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression.Hepatitis C virus infection, and neurological and psychiatric disorders - A review.Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV).Future directions for investigation of fatigue in chronic hepatitis C viral infection.Extrahepatic manifestations in chronic hepatitis C virus carriers.Integrative Review of Co-Occurring Symptoms Across Etiologies of Chronic Liver Disease and Implications for Symptom Management Research and Practice.Evidence for association between hepatitis C virus and Parkinson's disease.Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt.Functional connectivity alterations in patients with chronic hepatitis C virus infection: A multimodal MRI study.Hepatitis C virus infection: a risk factor for Parkinson's disease.Effect of Ondansetron, a 5-HT(3) receptor antagonist, on fatigue in 2 veterans with hepatitis C.Health-related quality of life among blood donors with hepatitis B and hepatitis C: longitudinal study before and after diagnosis.Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.Systemic abnormalities in liver disease.Hepatitis C virus infection and health-related quality of life.Hormone therapy in Brazilian postmenopausal women with chronic hepatitis C: a pilot study.Hepatitis C Virus Infection in the Older Patient.Association between hepatitis C virus infection and Parkinson's disease.Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C.Metabolic correlates of health-related quality of life among overweight and obese adolescents.Cognitive improvement after HCV eradication: Extending the benefits.

P2860

Q22306452-CC558B25-B9E7-4C5A-B103-BD91F5E76940 Q26767084-50FE1CAF-8D4F-40B2-8384-A7DD48130313 Q27489431-A7F1ABD1-463A-4D4F-9554-0144C9FAC24D Q28082212-A96903F8-960B-435B-884A-3EED6F7B55D6 Q31024615-D5EBD877-E99B-4AA3-ADD3-0A67154B27D7 Q33645706-870C0A24-5A31-48C5-BE67-F7E2721B697C Q33806972-928ABA93-34BF-4EAF-8D24-630A33360C6D Q34256005-ECF8D99B-E718-4F5D-A670-4F32CAF9F01C Q35534180-12525420-F04F-452F-976E-B7B276CAE62A Q35677347-E65FE832-BEBA-4C16-8369-EC58ABCBDB33 Q36146367-86272F07-8526-4550-95B6-E0D6AD708489 Q36266948-8AEA8B56-EBB4-4D82-A0FB-E07D21B61C51 Q36626299-E10EBBC9-4784-4DAE-A4CC-D107B2D4D12D Q36638638-F34B99A3-30B1-406B-89C5-8F2A95B34821 Q37016316-CA00AA60-BCB4-4278-A692-ECD3B3895C95 Q37333822-F70137E9-9F8D-4B63-8695-D152ED811580 Q37432877-CF776CB6-5507-4EB4-B22F-E745F8B8AF4D Q37497860-64B3FA56-FE28-4BE2-B52D-3D32CBC32ACB Q38388423-D8A7E47B-3887-4C90-A1B7-4E74FF71C14E Q38528645-BB2E3CF6-8ECD-49B9-AAC2-E515C51F1A9E Q38638550-C3E7DEB3-0001-4A8A-BE3A-CE79B3213776 Q38895939-6548AE90-4361-4E31-AD70-E75FF60FD773 Q40463925-0B53EF08-8B5D-4F71-8739-A7B5368BC11E Q41530271-C9BEC010-79D2-4F9B-BD92-CEB4E2A1682D Q41881617-3FF67C89-92CC-4956-9BAE-6E2FE376D082 Q41887081-3E714C8F-5CB6-4BBD-A46F-D0370CEAC49A Q42232478-70299FD4-DC2A-4412-AE0E-35CD487B0548 Q42623529-DDA6644D-6404-432E-A409-06CF9EFC2A3A Q43174497-B1C124A0-B8DF-48A4-860A-D2F46A5F9799 Q43297967-357CA0F9-68F0-4C14-972D-4F808C1F5EA8 Q45325560-0090F675-780B-4096-9318-9EA7CEEC9844 Q45333760-5EA1FCB8-1E34-41C0-AA60-1C37CA9D2222 Q46747507-1D0458DC-2725-4A1C-8CA3-1C6A9B5BCA7A Q48110978-B73001EE-169B-4941-8A29-D614CB3F45E6 Q50548502-9EB456BC-8704-4DCD-9242-ADBB192AC658

P2860

Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

http://www.wikidata.org/entity/Q35769113

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@ast

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@en

type

label

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@ast

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@en

prefLabel

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@ast

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@en

P1433

Q35769113-4E7A2018-412B-4BE0-85EA-805920A5AA45

P1476

Q35769113-1C4C8094-D85D-4E53-9D79-2826E5A84A06

P2093

Q35769113-043E93F1-8D7A-404E-9AF0-9391027F7589

Q35769113-13755CB2-80F1-4CEC-BC37-5C5C6D74F8D4

Q35769113-1A188E25-0CBD-4E9F-9B0D-C8B26511DAD3

Q35769113-4177FD0D-BEC5-4DFF-9F87-051887574745

Q35769113-667B6FDE-1100-4BA7-BC80-C716F726BA81

Q35769113-AFC95D11-2273-414C-A58C-8A470E35CD4E

Q35769113-E1E24824-992A-468D-8C6B-18E492C2E185

Q35769113-EA1EDBB0-F3E0-4BE8-9153-1C4AC5C4DB48

Q35769113-F90B4CEF-A262-49D9-9A71-C665186CE2C1

P2860

Q35769113-020ABD7F-8A2D-4927-B2E9-4E64FA8D2913

Q35769113-08F2C4CB-20FF-4C38-A11A-736A9162A1E1

Q35769113-113BBA33-6D95-4737-A681-5489E46C01D4

Q35769113-19DC9395-DD19-4943-95F8-60E996259642

Q35769113-34DB9624-5F19-472B-A8D6-D8CF36AB90EA

Q35769113-362FB824-DC0C-42AB-AB64-2DC9CC3BFFE5

Q35769113-40EE8C88-5D05-4811-855D-3EF5393D4E73

Q35769113-4C26AF91-2324-4A8C-AADC-9C42D969A6D8

Q35769113-5415F1D3-9E91-4C1B-9F7D-C6E4D7A555AE

Q35769113-65E09F0F-CFE0-4BD9-80DF-D00A63AEAAEA

P304

Q35769113-3293570F-BBE8-468F-A7EF-F18C8788F7F6

P31

Q35769113-A7E76175-BA94-4531-84D2-CE2D4E2F1659

P356

Q35769113-65C1C419-494A-47CF-B6FD-D9A0785039DC

P407

Q35769113-93C6EDAE-AEEE-498D-B597-D06B9C07D2AD

P433

Q35769113-77B9C97D-0E72-4708-8246-A821A83A8C7F

P478

Q35769113-F036BA11-C0BA-4B3B-8DE4-FC7F00EC18AE

P577

Q35769113-7B65D061-0C2C-4DFA-B632-B117D7DA9454

P5875

Q35769113-20337E3B-C24D-4DBB-8607-966102D17C3F

P698

Q35769113-176FD4F4-C525-4AF3-AF1C-F47D89273E7A

P932

Q35769113-31A01C18-66CB-43E8-85C9-B28B61468296

P356

GUT.2005.080267

P1433

P1476

Monoaminergic neurotransmissio ...... igue and cognitive impairment.

@en

P2093

B Ahl

http://www.w3.org/2001/XMLSchema#string

C Trebst

http://www.w3.org/2001/XMLSchema#string

G Berding

http://www.w3.org/2001/XMLSchema#string

H Hecker

http://www.w3.org/2001/XMLSchema#string

H Tillmann

http://www.w3.org/2001/XMLSchema#string

J C Ennen

http://www.w3.org/2001/XMLSchema#string

K Weissenborn

http://www.w3.org/2001/XMLSchema#string

M Bokemeyer

http://www.w3.org/2001/XMLSchema#string

U Wurster

http://www.w3.org/2001/XMLSchema#string

P2860

An Inventory for Measuring Depression

Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

The hospital anxiety and depression scale

Hepatitis C virus infection

Emerging evidence of hepatitis C virus neuroinvasion.

The impact of diagnosis of hepatitis C virus on quality of life.

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.

The human raphe nuclei and the serotonergic system.

P304

1624-1630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.080267

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7099531

http://www.w3.org/2001/XMLSchema#string

P698

16682431

http://www.w3.org/2001/XMLSchema#string

P932

1860082

http://www.w3.org/2001/XMLSchema#string